After participating in this educational activity, attendees should be able to:
1. Explain the risk and typical treatment strategy for thrombotic events in patients antiphospholipid syndrome (APS)
2. Identify challenges in monitoring activated partial thromboplastin time (aPTT) in patients with APS.
3. Discuss strategies for monitoring heparin antifactor Xa levels in patients receiving unfractionated heparin and its correlation to aPTT levels.
Leah Mangini, PharmD
PGY1 Pharmacy Resident
Baystate Medical Center
None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.
- 1.00 ACPE Contact Hours